Genetic Technologies Ltd. ADR (GENE) Social Stream



Genetic Technologies Ltd. ADR (GENE): $1.21

0.05 (+4.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Genetic Technologies Ltd (GENE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Genetic Technologies Ltd.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $25.65 $25.65 $25.65 $2.86 796.85%

Price Target Last Issued November 30, 2016

GENE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GENE as an investment opportunity.

  • The number of analysts covering the stock of GENE is higher than just about none of of all US stocks.
  • The variance in analysts' estimates of GENE is less than almost 100% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of GENE is greater than 98.17% of all US stocks.
  • Genetic Technologies Ltd's average analyst price target is greater than 84.82% of stocks in the micro market cap category.

Is GENE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6492 seconds.